Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
PFIZER reported a dip in second-quarter profits on Tuesday, but boosted its forecast due in part to higher revenues from cancer drugs and global vaccines.
Earnings for the pharmaceutical giant for the quarter ending June 28 were US$2.6 billion, down 9.8 per cent from the...